GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% Solution is indicated as a replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients ≥2 years.

Intended for US Healthcare Professionals only

    GAMMAGARD LIQUID

    Vial Sizes and Storage

    Potential for less waste

    GAMMAGARD LIQUID is offered in a broad range of vial sizes: 1 g (10 mL), 2.5 g (25 mL), 5 g (50 mL), 10 g (100 mL), 20 g (200 mL), and 30 g (300 mL). With 6 options, you have potential to reduce product waste.1

    How many grams are you potentially wasting?

    Select average number of patients on intravenous immune globulin (IVIG) in your practice.

    • 10
    • 20
    • 30
    • 40
    • 50
    • 60
    • 70
    • 80
    • 90

    If you are using an IVIG product with minimum dose of 5 g every 4 weeks, you could be wasting approximately:

    Monthly

    40

    g

    Yearly

    520

    g

    Convenient vial sizes1

    SizeGrams ProteinNDC
    10 mL1 g0944-2700-02
    25 mL2.5 g0944-2700-03
    50 mL5 g0944-2700-04
    100 mL10 g0944-2700-05
    200 mL20 g0944-2700-06
    300 mL30 g0944-2700-07

    Latex content in packaging

    • The packaging is not made with natural rubber latex 

    Shelf life/storage requirements

    • Up to 36 months at refrigerated temperature from the date of manufacture: 2°C-8°C (36°F-46°F)
    • Up to 24 months at room temperature from the date of manufacture: not to exceed 25°C (77°F)
    • Do not use past expiration date printed on label
    • Do not freeze

    Designed for ease of use in PI2

    • Using a 30 g vial may help reduce the number of vials required and reduce the need for handling
    • In a retrospective analysis of IVIG pharmacy claims (N=1,349)*:
      • 55% of patients received a dose of 30 g or higher
      • 30 g was the most frequently prescribed dose (nearly 1 in 5)
      • For patients receiving greater than 30 g, with a 30 g vial*:
        • 47% reduction in the number of vials needed
        • 97% of all prescriptions dispensed with 3 or fewer vials†

    *Based on a 2010 analysis of 1,354 patients with PI presenting 11,620 dispensing records.

    †Compared with 70% of prescriptions dispensed prior to the introduction of the 30 g vial.

    Test tube icon.

    How is GAMMAGARD LIQUID manufactured?

    Every step of the process, from collection to manufacturing and delivery, ensures reliable, well-controlled, and high safety margins.1

    How is GAMMAGARD LIQUID manufactured?

    References:

    1. GAMMAGARD LIQUID. Prescribing Information. Takeda Pharmaceuticals U.S.A., Inc.; 2024.
    2. Data on file. Analysis of potential vial reduction 30 g size. Baxter Healthcare Corporation.